VERTEX PHARMACEUTICALS/ US92532F1003 /
29/04/2024 20:01:02 | Diferencia -21.85 | Volumen | Bid20:30:00 | Ask20:30:00 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
371.75EUR | -5.55% | 3 Volumen de negocios: 1,115.25 |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 105.51 mil millonesEUR | - | - |
Newsfile Corp
21:03
Mamboleo Media Group Unveils Inspirational Children's Book: "Believing in the Secret"
GlobeNewswire
21:00
Sysco Celebrates Grand Opening of New State-of-the-Art Distribution and Culinary Center
GlobeNewswire
21:00
Dexfly Collaborates with Top Global Banks to Launch Digital Asset Custody Services
GlobeNewswire
21:00
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and ...
Newsfile Corp
20:59
ClaimsMate Launches Blog to Empower Policyholders in Navigating Insurance Claims
GlobeNewswire
20:52
Digital Brands Group to Report First Quarter 2024 Financial Results on Monday, May 20, 2024
GlobeNewswire
20:30
Kamari Pharma Announces New Data Presented at the 81st Annual Meeting of the Society for Investigati...
GlobeNewswire
20:26
Gainey McKenna & Egleston Announces A Second Class Action Lawsuit Has Been Filed Against Agilon Heal...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página